IP Library Granted Patent US 9,045,657
Granted Patent B2
US 9,045,657 · App. 13/636,542 · Granted Jun 2, 2015

Viscoelastic ink for direct writing of hydrogel structures

Inventors: Jennifer A. Lewis (Urbana, IL); Robert F. Shepherd (St. Paul, MN); Robert A. Barry, III (Beaverton, OR); Sara T. Parker (Portland, OR); Jennifer N. H. Shepherd (St. Paul, MN); Pierre Wiltzius (Santa Barbara, CA); Ralph G. Nuzzo (Champaign, IL)
Assignee: The Board of Trustees of the University of Illinois
C09D11/16C09D11/10A61L27/16A61L27/26A61L27/52A61L27/56C09D11/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,045,657
App. No.
13/636,542
Granted
Jun 2, 2015
Kind
B2
Abstract

A viscoelastic ink for direct writing of hydrogel structures includes a long chain polymer and a photopolymerizable moiety, which may be a photopolymerizable monomer or a photopolymerizable group attached to the long chain polymer. The ink may also include a crosslinking agent, a photoinitiator, and water. The long chain polymer is present at a concentration greater than a critical overlap concentration c* of the long chain polymer in the ink.

Claims (29)

1. A viscoelastic ink for direct writing of hydrogel structures, the ink comprising:

a polymer;

a photopolymerizable moiety;

a photoinitiator; and

water,

wherein the polymer comprises poly(hyaluronic acid) (pHA), methacrylated hyaluronic acid or a blend of the two and is present at a concentration of about 5 wt. % or greater in the ink.

2. The ink of claim 1 , wherein the photopolymerizable moiety is selected from the group consisting of: a photopolymerizable monomer; and a photopolymerizable group attached to the polymer.

3. A method for forming a hydrogel scaffold, the method comprising:

forming an ink comprising a polymer and a photopolymerizable moiety, the polymer comprising poly(hyaluronic acid) (pHA), methacrylated hyaluronic acid or a blend of the two and being present at a concentration of about 5 wt. % or greater in the ink;

extruding the ink through a micronozzle to form an extruded filament;

photopolymerizing the extruded filament; and

depositing the extruded filament in a pattern on a substrate to form a hydrogel scaffold,

wherein the ink comprises a first viscosity at a low shear rate of about 0.1 s −1 and a second viscosity during the extrusion, the second viscosity being at least about an order of magnitude lower than the first viscosity.

4. The method of claim 3 , wherein the second viscosity is about 20 Pa·s or less.

5. The method of claim 3 , wherein the photopolymerization of the extruded filament occurs prior to depositing the extruded filament on the substrate.

6. The method of claim 3 , wherein the photopolymerization of the extruded filament occurs after depositing the extruded filament on the substrate.

7. The method of claim 3 , further comprising, after the photopolymerization, chemically treating the hydrogel scaffold to render the scaffold compliant for tissue growth.

8. The method of claim 7 , wherein chemically treating the scaffold comprises immersing the scaffold in a polylysine solution.

9. The method of claim 3 , wherein the concentration of the polymer is between about 10 wt. % and about 50 wt. %.

10. The method of claim 3 , wherein the photopolymerizable moiety comprises a photopolymerizable monomer present at a concentration of between about 25 wt. % and 55 wt. %.

11. The method of claim 3 , wherein the photopolymerizable moiety comprises a photopolymerizable group attached to the polymer.

12. The method of claim 3 , wherein, after photopolymerization, the extruded filament comprises a physically entangled polymer network and a chemically crosslinked polymer network.

13. The method of claim 3 , wherein, after photopolymerization, the extruded filament comprises a chemically crosslinked polymer network with no physically entangled polymer chains.

14. The ink of claim 1 , wherein the ink further comprises polyethylene glycol diacrylate (PEGDA).

15. The ink of claim 14 , wherein the PEGDA is present at a concentration in the ink of up to about 10 wt. %.

16. The ink of claim 15 , wherein the concentration of the pHA, the methacrylated hyaluronic acid, or said blend of the two is 10 wt. % and the concentration of the PEGDA is 8 wt. %.

17. The method of claim 3 , wherein the ink further comprises polyethylene glycol diacrylate (PEGDA).

18. The method of claim 16 , wherein the PEGDA is present at a concentration in the ink of up to about 10 wt. %.

19. The method of claim 18 , wherein the concentration of the pHA, the methacrylated hyaluronic acid, or said blend of the two is 10 wt. % and the concentration of the PEGDA is 8 wt. %.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2015
From: LEWIS, JENNIFER A.; SHEPHERD, ROBERT F.; BARRY, ROBERT A., III; PARKER, SARA T.; SHEPHERD, JENNIFER N.H.; WILTZIUS, PIERRE; NUZZO, RALPH G.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 035535/0474 →
Continuity (2)
Provisional Application 61317076 · Mar 24, 2010
Related Publication 20130084449A1 · Apr 4, 2013